John Morici - 20 Feb 2026 Form 4 Insider Report for ALIGN TECHNOLOGY INC (ALGN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Feb 2026, 20:01:58 UTC
Prior SEC filing
20 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Julie Ann Coletti, Attorney-in-Fact for John Morici

Key filing fact

John Morici filed Form 4 for ALIGN TECHNOLOGY INC (ALGN) on 24 Feb 2026.

Key facts

  • This page summarizes John Morici's Form 4 filing for ALIGN TECHNOLOGY INC (ALGN).
  • 9 reported transactions and 7 derivative rows are listed below.
  • Accepted by SEC: 24 Feb 2026, 20:01.

Change

  • Previous filing in this sequence was filed on 20 Feb 2026.
  • Current net transaction value: -$484,361.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001689552 Primary reporting owner

Morici John

Relationship
EVP, CHIEF FINANCIAL OFFICER
Address
C/O ALIGN TECHNOLOGY, INC., 410 N. SCOTTSDALE ROAD, SUITE 1300, TEMPE
Signature
/s/ Julie Ann Coletti, Attorney-in-Fact for John Morici
Signature date
24 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALGN transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+7,848
Change %
+95%
Price
$0.000000
Shares after
16,085
Date
20 Feb 2026
Ownership
Direct
ALGN transaction

Common Stock

Tax liability

Transaction value
$484,361
Shares
-2,549
Change %
-16%
Price
$190.02
Shares after
13,536
Date
20 Feb 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALGN transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+8,423
Change %
Price
$0.000000
Shares after
8,423
Date
20 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,423
Exercise price
$0.000100
Footnotes
F1, F2
ALGN transaction Derivative

Market Stock Unit

Award

Transaction value
$0
Shares
+17,102
Change %
Price
$0.000000
Shares after
17,102
Date
20 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,102
Exercise price
$0.000100
Footnotes
F1, F3
ALGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-837
Change %
-33%
Price
$0.000000
Shares after
1,674
Date
20 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
837
Exercise price
$0.000100
Footnotes
F1, F4
ALGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-1,251
Change %
-25%
Price
$0.000000
Shares after
3,750
Date
20 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,251
Exercise price
$0.000100
Footnotes
F1, F5
ALGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-389
Change %
-100%
Price
$0.000000
Shares after
0
Date
20 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
389
Exercise price
$0.000100
Footnotes
F1, F6
ALGN transaction Derivative

Market Stock Unit

Options Exercise

Transaction value
$0
Shares
-4,653
Change %
-100%
Price
$0.000000
Shares after
0
Date
20 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,653
Exercise price
$0.000100
Footnotes
F1, F7
ALGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-718
Change %
-50%
Price
$0.000000
Shares after
718
Date
20 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
718
Exercise price
$0.000100
Footnotes
F1, F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Represents par value of ALGN common stock.

Footnote F2

1/4th of the restricted stock unit granted on February 20, 2026 will become vested on February 20, 2027 and shares will be delivered to reporting person on such date. 1/4th of restricted stock unit will vest annually thereafter and shares will be delivered to reporting person on such vest date.

Footnote F3

Represents the number of shares which may be issued at target under the market stock unit. If performance exceeds target, the maximum number of shares that may vest is 250% of the at target amount. Vesting, if any, of the market stock unit occurs on the last day of the third year of the Performance Period (as defined in the market stock unit agreement).

Footnote F4

1/4th of the restricted stock unit granted on February 20, 2024 became vested on February 20, 2026 and shares were delivered to reporting person on such grant date. 1/4th of the restricted stock unit will continue to vest annually and shares will be delivered to reporting person on each such vest date.

Footnote F5

1/4th of the restricted stock unit granted on February 20, 2025 became vested on February 20, 2026 and shares were delivered to reporting person on such grant date. 1/4th of the restricted stock unit will continue to vest annually and shares will be delivered to reporting person on each such vest date.

Footnote F6

1/4th of the restricted stock unit granted on February 20, 2022 became vested on February 20, 2026 and shares were delivered to reporting person on such grant date.

Footnote F7

The market stock unit granted on February 20, 2023 became vested on February 20,2026 and shares were delivered to reporting person on such vest date.

Footnote F8

1/4th of the restricted stock unit granted on February 20, 2023 became vested on February 20, 2026 and shares were delivered to reporting person on such grant date. 1/4th of the restricted stock unit will continue to vest annually and shares will be delivered to reporting person on each such vest date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .